Análisis de los factores de riesgo cardiovascular en el código ictus. Una aproximación en edades avanzadas / Analysis of cardiovascular risk factors in the stroke code. An approach in advanced ages

FUNDAMENTOS: El presente estudio tuvo como propósito analizar el efecto de los factores de riesgo cardiovascular (FRCV) en 153 pacientes de la provincia de Ourense que habían sufrido ictus, donde se había activado el código ictus. Su realización parte del propósito de los autores de incidir en la patología crónica para prevenir este evento en concreto. MÉTODOS: Se realizó un estudio longitudinal, retrospectivo y observacional aplicado a 153 pacientes con una media de edad de 76±12 años que habían presentado algún de tipo de ictus. Las variables independientes fueron clasificadas en cuantitativas (índice internacional normalizado [INR], presión arterial y glucemia) y en cualitativas (fibrilación auricular [FA], consumo de anticoagulantes [ACO], hábito de fumar y nivel de lípidos en sangre). Las variables dependientes fueron el tipo de ictus, la arteria afectada y la mortalidad de paciente al cabo de treinta días, seis meses y un año. Para las variables cualitativas se utilizó el método de comprobación no paramétrico de Kruskal-Wallis (K-W) y Mann-Whitney (M-W) para comparación de medias y para asociación Chi-cuadrado. RESULTADOS: El INR resultó asociado con el tipo de evento así como con la mortalidad a seis y doce meses (p<0,001). La glucemia se relacionó de forma estadísticamente significativa tanto con el tipo de evento como con la arteria afectada, así como con la mortalidad en los tres periodos. Tanto la FA como los ACO se asociaron con el tipo de evento y con la arteria afecta, los últimos además con la mortalidad a un año. La edad se relacionó con la mortalidad en los tres periodos sin llegar a ser significativa a los treinta días. Ser hombre podría ser un factor de riesgo (OR>1) para la mortalidad a treinta días y ser mujer para la mortalidad a un año . En cuanto al tipo de intervención realizada someterse a fibrinolisis o a trombectomía aumentó el riesgo de mortalidad frente al tratamiento combinado, siendo estadísticamente...(AU)

BACKGROUND: The purpose of this study was to analyze the effect of cardiovascular risk factors (CVRF) in 153 patients who had suffered a stroke in the province of Ourense and where the stroke code had been activated.Its realization is part of the purpose of the authors to influence chronic pathology to prevent this specific event. METHODS: A longitudinal, retrospective and observational study was applied to 153 patients with a mean age of 76±12 years who had presented some type of stroke. The independent variables were classified as quantitative (international normalized ratio [INR], blood pressure and glycemia) and in qualitative (atrial fibrillation [AF], consumption of anticoagulants [ACO], smoking and blood lipid levels). The dependent variables were the type of stroke, the affected artery, and patient mortality after thirty days, six months, and one year. For the qualitative variables, the non-parametric verification method of Kruskal-Wallis (K-W) and Mann-Whitney (M-W) was used for comparison of means and for Chi-square association. RESULTS: INR was associated with the type of event and mortality at six and twelve months (p<0,001). Glycemia was related in a statistically significant way both with the type of event, the affected artery and with mortality in the three periods. Both AF and OACs were associated with the type of event and the artery affected, the latter also with one-year mortality. Age was related to mortality in the three periods without becoming significant at thirty days. Being a man could be a risk factor for thirty -day mortality (OR>1) and being a woman for one-year mortality. Regarding the type of intervention performed, undergoing fibrinolysis or thrombectomy increased the risk of mortality compared to combined treatment, the relationship between thrombectomy and increased mortality being statistically significant exclusively in the six-month period...(AU)

Sleep quality analysis in individuals with acute coronary syndrome / Análisis de la calidad del sueño en individuos con síndrome coronario agudo / Análise da qualidade do sono em indivíduos com síndrome coronariana aguda

ABSTRACT Objective: to assess the prevalence of sleep disturbances and factors associated with sleep quality in patients with Acute Coronary Syndrome. Method: this is a cross-sectional study, carried out in the Cardiology Unit of a public university hospital, from October 2021 to December 2022, with patients hospitalized for Acute Coronary Syndrome over 18 years old. Sociodemographic and clinical data were collected, and sleep quality was measured by the Pittsburgh Sleep Quality Index. Statistical association tests were performed, considering a value of p<0.05 as significant. Results: a total of 96 patients were included, the majority being male, married and with a mean age of 63 years. The most prevalent comorbidities were hypertension, dyslipidemia and diabetes. It was identified that 92% had alteration in sleep quality and that the number of hours slept (p.<0.01), time to start sleep (p.0.03), sleep latency (p.<0.01), sleep duration (p.<0.01), habitual sleep efficiency (p.<0.02) and daytime sleepiness and daytime dysfunction (p.0.01) were significantly associated with sleep quality. There was a weak but significant correlation between age (r-0.22, p.0.02) and the presence of obstructive coronary lesions (r-0.23; p.0.02) with the Pittsburgh Sleep Quality Index score. Conclusion: most patients with acute coronary syndrome were classified as poor sleepers, therefore educational interventions to promote sleep should be performed in this population to reduce cardiovascular risk.

RESUMEN Objetivo: evaluar la prevalencia de trastornos del sueño y factores asociados a la calidad del sueño en pacientes con Síndrome Coronario Agudo. Método: estudio transversal, realizado en la Unidad de Cardiología de un hospital universitario público, de octubre de 2021 a diciembre de 2022, con pacientes hospitalizados por Síndrome Coronario Agudo mayores de 18 años. Se recogieron datos sociodemográficos y clínicos, y la calidad del sueño se midió mediante el Índice de Calidad del Sueño de Pittsburgh. Se realizaron pruebas de asociación estadística, considerando significativo un valor de p<0,05. Resultados: se incluyeron 96 pacientes, la mayoría hombres, casados ​​y con una edad media de 63 años. Las comorbilidades más prevalentes fueron hipertensión arterial sistémica, dislipidemia y diabetes. Se identificó que el 92% presentaba cambios en la calidad del sueño y que la cantidad de horas dormía (p.<0,01), tiempo de inicio del sueño (p.0,03), latencia del sueño (p.<0,01), duración del sueño (p.<0,01), eficiencia del sueño (p.<0,02) y somnolencia diurna y disfunción diurna (p.0,01) se asociaron significativamente con la calidad del sueño. Hubo una correlación débil pero significativa entre la edad (r-0,22, p.0,02) y la presencia de lesiones coronarias obstructivas (r-0,23; p.0,02) con el puntaje del Pittsburgh Sleep Quality Index. Conclusión: la mayoría de los pacientes con Síndrome Coronario Agudo fueron clasificados como insomnes, por lo que se deben realizar intervenciones educativas para promover el sueño en esta población para reducir el riesgo cardiovascular.

RESUMO Objetivo: avaliar a prevalência de distúrbios do sono e os fatores associados à qualidade do sono em pacientes com Síndrome Coronariana Aguda. Método: estudo transversal, realizado na Unidade de Cardiologia de um hospital público universitário, no período de outubro de 2021 a dezembro de 2022, com pacientes hospitalizados por Síndrome Coronariana Aguda maiores de 18 anos. Foram coletados dados sociodemográficos e clínicos, e a qualidade do sono foi mensurado pelo Índice de Qualidade do Sono de Pittsburgh. Testes estatísticos de associação foram realizados, sendo considerado um valor de p<0,05 como significativo. Resultados: foram incluídos 96 pacientes, sendo a maioria do sexo masculino, casados e com idade média de 63 anos. As comorbidades mais prevalentes foram hipertensão arterial sistêmica, dislipidemia e diabetes. Foi identificado que 92% tinham alteração na qualidade do sono e que a quantidade de horas dormidas (p.<0,01), o tempo para iniciar o sono (p.0,03), a latência do sono (p.<0,01), duração do sono (p.<0,01), eficiência do sono (p.<0,02) e sonolência diurna e disfunção diurna (p.0,01) apresentaram associação significativa com a qualidade do sono. Houve correlação fraca, porém, significativa entre a idade (r-0,22, p.0,02) e a presença de lesões obstrutivas coronarianas (r-0,23; p.0,02) com o escore do Pittsburgh Sleep Quality Index. Conclusão: a maioria dos pacientes com Síndrome Coronariana Aguda foram classificados como maus dormidores, portanto intervenções educativas para promoção do sono devem ser realizadas nesta população para a redução no risco cardiovascular.

Síndrome metabólico y su correlación con ecuaciones de predicción del riesgo global de enfermedad cardiovascular / Metabolic Syndrome and its Correlation with Prediction Equations of Global Risk for Cardiovascular Disease

Introducción: El síndrome metabólico constituye un hito en la investigación de evaluar mejor y de manera óptima el riesgo de enfermedad cardiovascular aterosclerótica. Objetivo: Analizar la correlación entre la capacidad predictiva del riesgo global de enfermedad cardiovascular aterosclerótica del síndrome metabólico y las tablas de riesgo: Framingham Risk Score, la tabla de la OMS/ISH y las de Gaziano, la ecuación PROCAM y el algoritmo QRISK2. Métodos: Se realizó una revisión documental, para lo cual se empleó la bibliografía nacional e internacional, especialmente la publicada en los últimos 5 años. Se utilizó el motor de búsqueda Google Académico y se consultaron artículos de libre acceso en las bases de datos Pubmed y SciELO desde marzo 2020 hasta el mes de enero 2021. Se emplearon como palabras clave: síndrome metabólico, riesgo cardiovascular global, método de estimación de riesgo y sus equivalentes en inglés. Las unidades de análisis fueron artículos originales, de revisión, incluyendo revisiones sistemáticas publicadas en los idiomas español e inglés. Fueron seleccionados 38 artículos (23 en idioma español, 15 en inglés) y 31 (81,5 por ciento) corresponden a los últimos 5 años. Conclusiones: El síndrome metabólico y los sistemas de estimación del riesgo global de enfermedad cardiovascular aterosclerótica no deben ser utilizados como equivalentes a causa de que su concordancia, en sentido general, es muy cuestionable. No obstante, se puede considerar como una herramienta útil en prevención primaria de la enfermedad cardiovascular aterosclerótica, siempre y cuando no sustituyan el juicio clínico y se contemplen todas las excepciones y precauciones posibles en el momento de su aplicación(AU)

Introduction: Metabolic syndrome is a milestone within the research to assess better and optimally the risk of atherosclerotic cardiovascular disease. Objective: To analyze the correlation between the predictive capacity for the global risk of atherosclerotic cardiovascular disease of metabolic syndrome and the risk tables: Framingham Risk Score, the WHO/ISH and Gaziano tables, the PROCAM equation, and the QRISK2 algorithm. Methods: A documentary review was carried out, using national and international literature, especially published within the last five years. The Google Scholar search engine was used and open-access articles were consulted in the Pubmed and SciELO databases, from March 2020 to January 2021. The keywords used were síndrome metabólico [metabolic syndrome], riesgo cardiovascular global [global cardiovascular risk], método de estimación de riesgo [risk estimation method] and their English equivalents. The units of analysis were original review articles, including systematic reviews published in Spanish and English. Thirty-eight articles were selected (23 in Spanish and fifteen in English), 31 (81.5 percent) of which correspond to the last five years. Conclusions: Metabolic syndrome and global risk estimation systems for atherosclerotic cardiovascular disease should not be used as equivalents because their concordance, in general, is very questionable. Nevertheless, they can be considered a useful tool in the primary prevention of atherosclerotic cardiovascular disease, as long as they do not replace clinical judgment and all possible exceptions or precautions are considered at the time of their application(AU)

Biomarcadores cardiacos de aterotrombosis y su implicación en la estimación del riesgo de enfermedad cardiovascular / Cardiac biomarkers of atherothrombosis and their implication in estimating the risk of cardiovascular disease

Introducción: Las innovadoras estrategias para la estimación del riesgo cardiovascular que apelan al empleo de biomarcadores cardiacos de aterotrombosis, han evidenciado ser superiores en la estratificación del riesgo cardiovascular por encima de aquellas predicciones basadas exclusivamente en la evaluación de factores de riesgo tradicionales de manera aislada. Se realizó una revisión bibliográfica, análisis y categorización de diferentes artículos en las bases de datos Cumed, Lilacs, SciELO, Medline, los términos clave para la búsqueda fueron: homocisteína, lipoproteína (a) y riesgo cardiovascular, en español, inglés y portugués. Se consideraron artículos originales, de revisión, incluyendo revisiones sistemáticas y metaanálisis posteriores al año 2000. Objetivo: Analizar los biomarcadores cardiacos de aterotrombosis, involucrados en el desarrollo de la enfermedad cardiovascular aterosclerótica y sus complicaciones trombóticas. Desarrollo: La evidencia acumulada sustenta que biomarcadores cardiacos como la hiperhomocisteinemia, la hiperlipoproteinemia (a), el incremento de los niveles plasmáticos del fibrinógeno, el factor VII coagulante, el inhibidor del activador tisular del plasminógeno tipo 1 y la proteína C reactiva, son herramientas de gran utilidad para estratificar el riesgo cardiovascular en individuos de riesgo intermedio, o con riesgo inusual o de riesgo indefinido, esencialmente en el ámbito de la prevención primaria y secundaria de la enfermedad cardiovascular . Conclusiones: La identificación de biomarcadores emergentes de aterotrombosis predictivos adicionales, es trascendental para una prevención y terapéutica más eficaz de la enfermedad cardiovascular aterosclerótica(AU)

Introduction: Innovative cardiovascular risk estimation strategies that use cardiac biomarkers of atherothrombosis have been shown to be superior in cardiovascular risk stratification that those predictions based exclusively on the evaluation of traditional risk factors in isolation. A bibliographic review, analysis and categorization of different articles was performed in the databases Cumed, Lilacs, Scielo, Medline, the key terms for the search were: "homocysteine", "lipoprotein (a)" and "cardiovascular risk", in Spanish, English and Portuguese languages. Original review articles were considered, including systematic reviews and published meta-analyzes after 2000. Objective: To analyze some of the cardiac biomarkers of atherothrombosis that may be involved in the development of atherosclerotic cardiovascular disease and its thrombotic complications. Development: Accumulated evidence supports that cardiac biomarkers such as: hyperhomocysteinemia, hyperlipoproteinemia (a), increased plasma fibrinogen levels, coagulant factor VII, Plasminogen Tissue Activator Inhibitor type 1 and C-reactive protein are tools of Very useful for stratifying cardiovascular risk in those individuals with intermediate risk, or with unusual or undefined risk, essentially in the field of primary and secondary prevention of cardiovascular disease. Conclusions: The identification of additional predictive emergent atherothrombosis biomarkers is crucial for a more effective prevention and therapy of atherosclerotic cardiovascular disease(AU)

Risk factors and comorbidities associated with severe aortic stenosis: A case-control study.

BACKGROUND AND OBJECTIVE: Aortic stricture (AS) is one of the most prevalent cardiovascular diseases in individuals 65 years of age or older. A number of epidemiological studies have suggested that certain cardiovascular risk factors (CRFs) and comorbidities could be associated with AS. The aim of this study was to evaluate the association between CRFs and comorbidities and severe symptomatic AS in individuals 65 years of age or older in a Spanish healthcare region. PATIENTS AND METHODS: We conducted an epidemiological case-control study from a single primary care centre. We collected information on exposure to CRFs and comorbidities and determined their association with AS, employing adjusted odds ratios (OR) and multiple logistic regression models. RESULTS: The study included 102 cases (mean age, 77.6 years) and 221 controls (mean age, 75.5 years). The CRFs significantly associated with severe symptomatic AS were hypercholesterolaemia (OR, 2.67; p < .001), tobacco use (OR, 2.60; p < .001), hypertension (OR, 2.41; p = .010) and low HDL cholesterol readings (OR, 2.20; p = .007). The comorbidities significantly associated with severe symptomatic AS were carotid stenosis (OR, 14.5; p = .017), stroke (OR, 4.14; p = .024), chronic renal failure (OR, 3.78; p < .001) and low haemoglobin levels (OR, 0.76; p < .001). CONCLUSIONS: Hypercholesterolaemia, tobacco use, arterial hypertension and low HDL cholesterol levels are the CRFs with a greater risk of severe AS. Furthermore, this disease is associated with a number of comorbidities (chronic renal failure, stroke, carotid stenosis and low haemoglobin levels), which could be markers of AS.

Factores de riesgo y comorbilidades asociadas a la estenosis aórtica grave: estudio de casos y controles / Risk factors and comorbidities associated with severe aortic stenosis: a case-control study

Antecedentes y objetivo La estenosis aórtica (EA) es una de las enfermedades cardiovasculares más prevalentes en sujetos≥65años. Algunos estudios epidemiológicos sugieren que ciertos factores de riesgo cardiovascular (FRCV) y comorbilidades pueden estar asociados con la EA. El objetivo del estudio es evaluar la asociación de FRCV y comorbilidades con la EA grave sintomática en pacientes≥65años en una región sanitaria española. Pacientes y métodos Se realizó un estudio epidemiológico de casos y controles procedentes del mismo centro de atención primaria. Se recogió información sobre la exposición a FRCV y comorbilidades, y se determinó la asociación de ambos con la EA con odds ratio ajustadas (ORa), mediante modelos de regresión logística múltiple. Resultados Se incluyeron un total de 102 casos (edad media=77,6 años) y 221 controles (edad media=75,5 años). Los FRCV significativamente asociados con la EA grave sintomática fueron hipercolesterolemia (ORa=2,67; p<0,001), tabaquismo (ORa=2,60; p<0,001), hipertensión (ORa=2,41; p=0,010) y cifras bajas de colesterol-HDL (ORa=2,20; p=0,007). Las comorbilidades significativamente asociadas con la EA grave sintomática fueron estenosis carotídea (ORa=14,5; p=0,017), accidente vascular cerebral (ORa=4,14; p=0,024), insuficiencia renal crónica (ORa=3,78; p<0,001) y bajos niveles de hemoglobina (ORa=0,76; p<0,001). Conclusiones La hipercolesterolemia, el tabaquismo, la hipertensión arterial y los niveles bajos de colesterol-HDL son los FRCV que comportan mayor riesgo de EA grave. Asimismo, esta enfermedad se asocia con algunas comorbilidades (insuficiencia renal crónica, accidente vascular cerebral, estenosis carotídea y niveles de hemoglobina más bajos) que podrían ser marcadores de E (AU)

Background and objective Aortic stricture (AS) is one of the most prevalent cardiovascular diseases in individuals 65 years of age or older. A number of epidemiological studies have suggested that certain cardiovascular risk factors (CRFs) and comorbidities could be associated with AS. The aim of this study was to evaluate the association between CRFs and comorbidities and severe symptomatic AS in individuals 65 years of age or older in a Spanish healthcare region. Patients and methods We conducted an epidemiological case-control study from a single primary care centre. We collected information on exposure to CRFs and comorbidities and determined their association with AS, employing adjusted odds ratios (OR) and multiple logistic regression models. Results The study included 102 cases (mean age, 77.6 years) and 221 controls (mean age, 75.5 years). The CRFs significantly associated with severe symptomatic AS were hypercholesterolaemia (OR, 2.67; p<.001), tobacco use (OR, 2.60; p<.001), hypertension (OR, 2.41; p=.010) and low HDL cholesterol readings (OR, 2.20; p=.007). The comorbidities significantly associated with severe symptomatic AS were carotid stenosis (OR, 14.5; p=.017), stroke (OR, 4.14; p=.024), chronic renal failure (OR, 3.78; p<.001) and low haemoglobin levels (OR, 0.76; p<.001). Conclusions Hypercholesterolaemia, tobacco use, arterial hypertension and low HDL cholesterol levels are the CRFs with a greater risk of severe AS. Furthermore, this disease is associated with a number of comorbidities (chronic renal failure, stroke, carotid stenosis and low haemoglobin levels), which could be markers of AS (AU)

Risk factors and comorbidities associated with severe aortic stenosis: a case-control study. / Factores de riesgo y comorbilidades asociadas a la estenosis aórtica grave: estudio de casos y controles.

BACKGROUND AND OBJECTIVE: Aortic stricture (AS) is one of the most prevalent cardiovascular diseases in individuals 65 years of age or older. A number of epidemiological studies have suggested that certain cardiovascular risk factors (CRFs) and comorbidities could be associated with AS. The aim of this study was to evaluate the association between CRFs and comorbidities and severe symptomatic AS in individuals 65 years of age or older in a Spanish healthcare region. PATIENTS AND METHODS: We conducted an epidemiological case-control study from a single primary care centre. We collected information on exposure to CRFs and comorbidities and determined their association with AS, employing adjusted odds ratios (OR) and multiple logistic regression models. RESULTS: The study included 102 cases (mean age, 77.6 years) and 221 controls (mean age, 75.5 years). The CRFs significantly associated with severe symptomatic AS were hypercholesterolaemia (OR, 2.67; p<.001), tobacco use (OR, 2.60; p<.001), hypertension (OR, 2.41; p=.010) and low HDL cholesterol readings (OR, 2.20; p=.007). The comorbidities significantly associated with severe symptomatic AS were carotid stenosis (OR, 14.5; p=.017), stroke (OR, 4.14; p=.024), chronic renal failure (OR, 3.78; p<.001) and low haemoglobin levels (OR, 0.76; p<.001). CONCLUSIONS: Hypercholesterolaemia, tobacco use, arterial hypertension and low HDL cholesterol levels are the CRFs with a greater risk of severe AS. Furthermore, this disease is associated with a number of comorbidities (chronic renal failure, stroke, carotid stenosis and low haemoglobin levels), which could be markers of AS.

Risk stratification of coronary artery disease using radionuclides. Current status of clinical practice. / Estratificación de riesgo de enfermedad coronaria con métodos isotópicos. Estado actual de la práctica clínica.

A discussion is presented on the current use of radioisotopes for evaluation of coronary artery disease in relation to other available techniques. The review is focused on coronary artery disease risk stratification employing single photon emission computed tomography and positron emission tomography, as well as on ischaemic cardiomyopathy and myocardial viability applications. Concepts are presented regarding coronary blood flow reserve, diagnostic and prognostic values, criteria for its appropriate use, as well as current methods to reduce unnecessary patient irradiation, in order to optimise nuclear cardiology practice.

Dislipidemia aterogénica en Latino América: prevalencia, causas y tratamiento / Atherogenic dislipidemia in Latin America: prevalence, causes and treatment

En las guías clínicas actuales, la dislipidemia aterogénica (DA) es una entidad escasamente atendida. Debido a las frecuentes alteraciones en los lípidos asociados a la DA en Latino América (LA), se organizó un grupo de expertos que se ha denominado Academia Latino Americana para el estudio de los Lípidos (ALALIP) para generar un documento con análisis de su prevalencia y ofrecer recomendaciones prácticas. Se utilizó la metodología Delphi modificada, con revisión comprensiva de la literatura con énfasis en aquellas publicaciones con implicaciones para LA. Subsecuentemente, se desarrollaron preguntas claves para ser discutidas. En LA no existe un estudio global sobre los factores de riesgo que representan a la totalidad de la población. El análisis sistemático de las encuestas nacionales de salud y de los estudios sistemáticos de cohorte muestran consistentemente una alta prevalencia de las anormalidades lipídicas que definen la DA. La concentración baja del colesterol unido a las lipoproteínas de alta densidad (C-HDL) varía entre 34,1% a 53,3% y la de triglicéridos (TG) elevados del 25,5% al 31,2%, con mayor prevalencia entre los hombres. Múltiples causas se han reconocidos, como alta ingesta de alimentos de mayor densidad calórica, contenido de colesterol, grasas trans, sedentarismo y cambios epigenéticos. La DA bien puede ser tratada con los cambios terapéuticos del estilo de vida (CTEV) con incremento en la actividad física, ejercicio regular y dieta baja en carbohidratos y alta en ácidos grasos poliinsaturados, tales como los ácidos grasos omega-3 como intervención primaria. De ser necesario, esta estrategia sera suplementada con terapia farmacológica como la monoterapia con estatinas o la combinación de fibratos/ácidos grasos omega-3. Las anormalidades lipídicas que definen la DA tienen una elevada prevalencia en LA; su interacción con un estilo de vida no saludable, herencia y cambios epigenéticos están ligados a sus posibles causas. La DA es una causa importante de riesgo cardiovascular residual (RCVR) que debe ser diagnosticada y tratada. Es importante y necesario diseñar un estudio global de factores de riesgo en LA para conocer la real prevalencia de la DA.

In the current clinical guidelines, atherogenic dyslipidemia (AD) is a poorly recognized entity. Due to the frequent lipid alterations associated with AD in Latin America (LA), we organized a group of experts named Latin American Academy for the study of Lipids (ALALIP), to generate a document for analyzing its prevalence and to offer practical recommendations. Using the Delphi methodology, we conducted a comprehensive literature review, with emphasis on those publications with implications for LA. Subsequently we developed key questions to be discussed. In LA there is no a global study on risk factors that represent the entire population. The systematic analysis of national health surveys and regional cohort studies showed a consistent high prevalence of the lipid abnormalities that define AD. Low high density lipoprotein cholesterol (HDL-C) ranges from 34.1% to 53.3% and elevated triglycerides (TG) from 25.5% to 31.2%, more prevalent in men. There are multiple causes: high consumption of foods with a high caloric density, cholesterol and trans fats, sedentary lifestyle and epigenetic changes. AD must be well treated with therapeutic changes in lifestyle with increased in physical activities, regular exercise and a diet with a low proportion of carbohydrates y rich in poliunsatured fatty acid, such as omega-3 fatty acid as primary intervention. If needed, this strategie must be supplemented with pharmacological therapies such as monotherapy with statins or a combination of fibrates plus omega-3.fatty acid. Lipid abnormalities that define AD have a high prevalence in LA; the interaction between non-healthy lifestyle, inheritance and epigenetic changes, possibly are its cause. AD is an important cause of cardiovascular residual risk (CVRR), that must be diagnosed and treated. It is important and neccesary to design a global study of risk factors in LA to know the true prevalence of AD.

Homocisteína y otros factores de riesgo cardiovascular en niños de educación básica primaria del Colegio Distrital Manuel Elkin Patarroyo, Bogotá, D.C.Colombia. Estudio piloto / Homocysteine and other Cardiovascular Risk Factors in Elementary School Children of the School District "Manuel Elkin Patarroyo", Bogota, D.C. - Colombia. Pilot study

Resumen Objetivo. Evaluar los niveles de homocisteína total (tHcy) y su asociación con otros factores de riesgo cardiovascular (FRCV) en niños de educación básica primaria del Colegio Manuel Elkin Patarroyo. Método. Estudio descriptivo en 50 niños de 6 a 12 años, seleccionados mediante muestreo no probabilístico por conveniencia. Se cuantificaron niveles de tHcy, lípidos y glucosa, se midió presión arterial y se tomaron medidas antropométricas. Los estilos de vida se determinaron con formatos validados y se estableció el punto de corte para diagnosticar hiperhomocisteinemia (HHcy) en la población. Resultados. Las niñas presentaron concentraciones mayores de triglicéridos y c-VLDL que los niños (p=0.05). El valor medio de tHcy para la población general fue de 5.0 (±1,15) -imol/L y el punto de corte para HHcy 6.92 Limol/L. Presentaron HHcy 7.7% de las niñas y 12,5% de los niños. Del grupo con HHcy, 20% estaba en sobrepeso, 40% presentaba hipertensión, 20% expresó c-HDL disminuido, 62% tenía un consumo bajo de carne y 80% alta ingesta de hamburguesas, papas fritas y refrescos. Conclusiones. Aunque la HHcy no estuvo asociada con otros FRCV, es necesario implementar programas que permitan modificar estilos de vida inadecuados.

Abstract Objective .To assess levels oftotal homocysteine (tHcy) and its association with other cardiovascular risk factors (CRF) in elementary school children Manuel Elkin Patarroyo College. Methods. Descriptive study in 50 children aged 6 to 12 years, selected through non-probability convenience sampling. Levels of tHcy, lipids and glucose were measured, blood pressure was measured and anthropometric measurements were taken. The lifestyles were determined with validated formats and the cutoff was established to diagnose hyperhomocysteinemia (HHcy) in the population. Results. Girls had higher concentrations of triglycerides and VLDL-c than boys (p = 0.05). The mean tHcy in the general population was 5.0 (± 1.15) Limol/L and the cutoff for HHcy was 6.92 Limol/L. 7.7 % of girls and 12.5 % of the boys had HHcy. Among this group, 20% were overweight, 40% had hypertension, 20% expressed decrease c-HDL, 62% (31) had a low intake of meat, and 80% (4) high intake of hamburger, fries and soda. Conclusion. Although HHcy was not associated with other CVRF, it is necessary to implement programs that allowto modify inappropriate lifestyles.

Social Inequalities in Cardiovascular Risk Factors Among Older Adults in Spain: The Seniors-ENRICA Study.

INTRODUCTION AND OBJECTIVES: To examine the distribution of the main cardiovascular risk factors (CVRF) according to socioeconomic level (SEL) among older adults in Spain. METHODS: A cross-sectional study conducted in 2008-2010 with 2699 individuals representative of the noninstitutionalized Spanish population aged ≥ 60 years. Socioeconomic level was assessed using educational level, occupation, and father's occupation. The CVRF included behavioral and biological factors and were measured under standardized conditions. RESULTS: In age- and sex-adjusted analyses, higher educational level was associated with a higher frequency of moderate alcohol consumption and leisure time physical activity, and less time spent watching television. An inverse educational gradient was observed for frequency of obesity (odds ratio [OR] in university vs primary level or below education, 0.44; 95% confidence interval [95%CI], 0.33-0.57; P-trend < .01), metabolic syndrome (OR = 0.56; 95%CI, 0.43-0.71; P-trend < .01), diabetes (OR = 0.68; 95%CI, 0.49-0.95; P-trend < .05), and cardiovascular disease (OR = 0.52; 95%CI, 0.29-0.91; P-trend < .05). Compared with a nonmanual occupation, having a manual occupation was associated with a higher frequency of several CVRF; this association was stronger than that observed for father's occupation. Differences in CVRF across SELs were generally greater in women than in men. CONCLUSIONS: There are significant social inequalities in CVRF among older adults in Spain. Reducing these inequalities, bringing the levels of CVRF in those from lower SEL in line with the levels seen in higher SEL, could substantially reduce the prevalence of CVRF in the older adult population.

Dislipidemia aterogénica en latino américa: prevalencia, causas y tratamiento / Atherogenic dyslipidemia in Latin America: prevalence, causes and treatment

En las guías clínicas actuales, la dislipidemia aterogénica (DA) es una entidad no muy atendida. Debido a las frecuentes alteraciones en los lípidos asociados a la DA en Latino América (LA). Métodos: organizamos un grupo de expertos denominado Academia Latino Americana para el estudio de los Lípidos (ALALIP) para así generar un documento con análisis de su prevalencia y recomendaciones terapéuticas prácticas. Se utilizó la metodología Delphi modificada, con una revisión integral de la literatura y énfasis en las publicaciones con implicaciones para LA. Subsecuentemente, desarrollamos preguntas claves para ser discutidas. Resultados: En Latinoamérica (LA) no existe un estudio global sobre los factores de riesgo que representan a la totalidad de la población. El análisis sistemático de las encuestas nacionales de salud y de los estudios sistemáticos de cohorte muestran consistentemente una alta prevalencia de las anormalidades lipídicas que definen la DA. La concentración baja del colesterol unido a las lipoproteínas de alta densidad (C-HDL) varía entre 34,1% a 53,3% y la de triglicéridos (TG) elevados del 25,5% al 31,2%, con mayor prevalencia entre los hombres. La DA bien puede ser tratada con los cambios del estilo de vida (CTEV) como ncremento en laactividad física, dieta baja en carbohidratos y alta en ácidos grasos poliinsaturados, tales como los ácidos grasos omega-3 como intervención primaria. De ser necesario, esta estrategia sera suplementada con terapia farmacológica como la monoterapia con estatinas o la combinación de fibratos/ácidos grasos omega-3. Conclusiones: Las anormalidades lipídicas que definen la DA tienen una elevada prevalencia en LA; su interacción con un estilo de vida no saludable, herencia y cambios epigenéticos están ligados a sus posibles causas. La DA es una causa importante de riesgo cardiovascular residual (RCVR) que debe ser diagnosticada y tratada. Es importante y necesario diseñar un estudio global de factores de riesgo en LA para conocer la real prevalencia de la DA(AU)

In the current clinical guidelines, atherogenic Med Interna (Caracas) 2017; 33 (3): 121 - 139 Dislipidemia Aterogénica en Latino América: Prevalencia, causas y tratamiento Carlos I. Ponte-N, Jesús E. Isea-Pérez, Alberto J. Lorenzatti, Patricio López-Jaramillo, Fernando Stuardo Wyss-Q, Xavier Pintó, Fernando Lanas, Josefina Medina, Livia T. Machado-H, Mónica Acevedo, Paola Varleta Alfonso Bryce, Carlos Carrera, Carlos Ernesto Peñaherrera, José Ramón Gómez-M, Alfredo Lozada, Alonso Merchan-V, Daniel Piskorz, Enrique Morales, María Paniagua, Félix Medina-Palomino, Raúl Alejandro Villar-M, Leonardo Cobos, Enrique Gómez-Álvares, Rodrigo Alonso, Juan Colan, Julio Chirinos, Jofre Lara, Vladimir Ullauri, Ildefonso Arocha Documento de la posición de expertos de la Academia Latino Americana para el estudio de los Lípidos (ALALIP) y avalado por la Sociedad Interamericana de Cardiología (SIAC), Sociedad Sur Americana de Cardiología (SSC), el Colegio Panamericano de Endotelio (CPAE) y la Sociedad Internacional de Aterosclerosis (IAS). Publicado en conjunto con las Revistas de la Sociedad Venezolana de Medicina Interna y de la Sociedad Venezolana de ndocrinología y Metabolismo. dyslipidemia (AD) is a poorly recognized entity. Due to the frequent lipid alterations associated with AD in Latin America (LA), we organized a group of experts named Latin American Academy for the study of Lipids (ALALIP), to generate a document to analize it´s prevalence and to offer practical recommendations. Methodology: Using the Delphi methodology, we conducted a comprehensive literature review, with emphasis on those publications with implications for LA. Subsequently we developed key questions to be discussed. Results: In LA There is no a global study on risk factors that represent the entire population. The systematic analysis of national health surveys and regional cohort studies showed a consistent high prevalence of the lipid abnormalities that define AD. Low high density lipoprotein cholesterol (HDL-C) ranges from 34.1% to 53.3% and elevated triglycerides (TG) from 25.5% to 31.2% more prevalent in men. There are multiple causes: high consumption of foods with a high caloric density, cholesterol and trans fats, sedentary lifestyle and epigenetic changes. AD must be well treated with therapeutic changes in lifestyle with increase in physical activities, regular exercise and a diet with a low proportion of carbohydrates and rich in poliunsatured fatty acid, such as omega-3 fatty acids as primary intervention. If needed, this strategy must be supplemented with pharmacological therapies such as monotherapy with statins or a combination of fibrates plus omega-3. fatty acid. conclusions: Lipid abnormalities that define AD have a high prevalence in LA; the interaction between non-healthy lifestyle, inheritance and epigenetic changes, possibly are the cause. AD is an important cause of cardiovascular residual risk (CVRR), that must be diagnosed and treated It is important and necesary to design a global study of risk factors in LA to know the true prevalence of AD(AU)

Caracterización del infarto agudo de miocardio en pacientes atendidos en Centro Médico Diagnóstico Integral Ezequiel Zamora de Venezuela / Acute Myocardial Infarction Characterization in Patients Attended atEzequiel ZamoraIntegral Diagnosis Medical Centerof Venezuela

Introducción: el infarto de miocardio es la principal causa de muerte de hombres y mujeres en todo el mundo.Objetivo: caracterizar el infarto agudo de miocardio en los pacientes atendidos en el centro médico. Método: estudio de serie de casos de 34 pacientes mayores de 15 años ingresados por infarto de miocardio agudo desde diciembre 2009 a diciembre 2011, en el Centro Médico Ezequiel Zamora del municipio San Carlos, en el estado Cojedes, Venezuela. Los datos se recogieron de las historias clínicas.Resultados: el infarto agudo de miocardio predominó en el sexo masculino con el 79,41% y en pacientes ≥ 50 años (73,53%). Los factores de riesgo cardiovascular asociados fueron la hipertensión arterial (38,24%), diabetes mellitus (35,29%), dislipidemia (29,41%) y el hábito de fumar (20,59%). La forma de presentación más frecuente fue dolor anginoso con 25 pacientes (73,53%) y en menor medida el edema agudo del pulmón con el 26,47%. Solo 6 pacientes (17,65%) recibieron tratamiento fibrinolítico. Conclusiones: el infarto agudo de miocardio predominó en hombres ≥ 50 años con factores de riesgo cardiovascular y el tratamiento fibrinolítico se aplicó a un número pequeño de pacientes.(AU)

Introduction: myocardial infarction is the main cause of death for men and women worldwide.Objective: to characterize the acute myocardial infarction in patients treated at the medical center.Methods: a case series study in 34 patients over 15 years admitted for acute myocardial infarction from December 2009 to December 2011, at Ezequiel Zamora municipality Medical Center from San Carlos municipality, in Cojedes state, Venezuela. Data were collected from medical records.Results: acute myocardial infarction in males predominated with 79.41% and in patients ≥ 50 years (73.53%). The associated cardiovascular risk factors were hypertension (38.24%), diabetes mellitus (35.29%), dyslipidemia (29.41%) and smoking (20.59%). The most frequent form of presentation was angina pain with 25 patients (73.53%) and less acute lung edema with 26.47%. Only six patients (17.65%) received fibrinolytic therapy.Conclusions: acute myocardial infarction predominated in men ≥ 50 years with cardiovascular disease risk factors and fibrinolytic therapy was applied to a small number of patients.(AU)

Riesgo cardiovascular global en una población adulta mayor del área rural, Cantón de Garabito, Puntarenas / Global cardiovascular risk on an elderly population in a rural area in Garabito, Puntarenas, Costa Rica

Objetivo: determinar el riesgo cardiovascular global en las personas adultas mayores que asisten al Centro Diurno de Ancianos Josefina Ugalde, de Quebrada Ganado, Puntarenas. Métodos: estudio de tipo analítico y prospectivo, de una población adulta mayor que asiste al centro diurno. Entre agosto de 2012 y febrero de 2014, se recolectaron los datos demográficos, clínicos, biológicos y de gabinete. Se aplicó la escala de Framingham. Resultados: se estudió 61 personas (67% mujeres), con edad promedio de 75,7 años, sin diferencia estadística por sexo (p=0,199). La prevalencia de factores de riesgo cardiovascular fue: hipertensión arterial 68%; obesidad abdominal 59%; LDL elevado 48%; HDL bajo 39%; diabetes mellitus 37%; tabaquismo 32% y antecedentes cardiovasculares 18%. En los controles a los 12 y 18 meses, solamente demostraron una reducción significativa (p<0,001) en los niveles de LDL elevado (32%) y en el perímetro abdominal (40%). Los otros parámetros no se modificaron. A los 18 meses el riesgo cardiovascular global fue del 14%, distribuido de la siguiente manera: el 21,4% presentó riesgo cardiovascular bajo; el 47,6%, riesgo cardiovascular moderado, y el 31%, riesgo cardiovascular alto. Conclusión: los factores de riesgo cardiovascular clásicos de enfermedad aterosclerótica, son frecuentes y tratados de forma subóptima en la población estudiada, lo que se asocia a un riesgo cardiovascular global elevado.

Purpose: To determine the global cardiovascular risk of an elderly population attending the Josefina Ugalde Day-care Center for the Elderly in Quebrada Ganado, Puntarenas, Costa Rica. Methods: A prospective and analytical study of an elderly population that attends the day-care center. Between August 2012 and February 2014 demographic, clinical, biological and complementary studies were collected. The Framingham scale was used to determine cardiovascular risk. Results: A total of 61 persons were studied (67% female), the mean age of this population was 75.7 years; there was no statistical difference regarding gender (p=0.199). Cardiovascular risk factor prevalence was as follows: hypertension 68%, altered abdominal circumference 59%, elevated LDL cholesterol 48%, low HDL cholesterol 39%, diabetes mellitus 37%, smoking 32% and prior cardiovascular events 18%. Patient follow-up at 12 and 18 months revealed a relevant reduction (p< 0.001) in elevated LDL (32%) and abdominal circumference (40%). All other parameters remained unaltered. After 18 months, global cardiovascular risk was 14%, distributed as follows: 21.4% had low risk; 47.6% had moderate risk and 31% had high risk. Conclusion: The classic risk factors for atherosclerotic disease are frequent and treated in a suboptimal manner in the population studied. This is associated with a high global cardiovascular risk.

Prevalence of cardiovascular risk factors in Latin America: a review of the published evidence 2010-2015 / Prevalencia de factores de riesgo cardiovascular en América Latina: una revisión de la evidencia publicada de 2010 a 2015

Introduction: There are certain variables that help us to determine the probability of an individual developing cardiovascular disease, those variables are called risk factors. The more risk factors a person has, the more likely of cardiovascular disease. Objectives: To determine prevalence of cardiovascular risk factors in Latin America. Material and methods: A literature review published during the period 2010-2015, with the participation of Latin American countries, of which items were selected in English and Spanish data bases recognized worldwide as PubMed, OMIM, SCIELO, EBSCO and magazines cardiology and public health of each Latin American country. Results: Identified 3,645 articles of which 45 were selected; after examine and evaluate the methodological framework of the 45 articles, the information of these variable allowed did add up the sample of the articles (n = 7,192,262) for conclude than latin american have a higher prevalence of overweight/obesity, physical inactivity, smoking and alcohol intake. Conclusions: In the Latin American population there is a high prevalence of cardiovascular risk factors without significant differences by gender.

Introducción: Existen ciertas variables que nos ayudan a determinar la probabilidad de desarrollo de enfermedades cardiovasculares; estas variables son llamados factores de riesgo. Cuanto más factores de riesgo tenga una persona, mayores probabilidades tendrá de padecer una enfermedad cardiovascular. Objectivos: Determinar la prevalencia de los factores de riesgo cardiovascular en Latinoamérica. Material y métodos: Una revisión bibliográfica de publicaciones durante el periodo 2010-2015, con la participación de paises de Latinoámerica, los cuales fueron seleccionados en inglés y español de bases de datos reconocidas a nivel mundial como PubMed, OMIM, SCIELO, EBSCO y revistas de cardiología y salud pública de cada país latinoamericano. Resultados: Se identificaron 3,645 artículos, de los cuales 45 fueron seleccionados; después de examinar y evaluar el marco metodológico de los 45 artículos, la información de estas variables permitió sumar la muestra de los artículos (n = 7,192,262) para concluir que los latinoamericanos tienen una alta prevalencia de sobrepeso/obesidad, sedentarismo, tabaquismo y alcoholismo. Conclusiones: En la población latinoamericana hay una alta prevalencia de los factores de riesgo cardiovascular sin diferencias significativas por género.

[Perception of cardiovascular risk in an outpatient population of the Madrid Community]. / Percepción de riesgo cardiovascular en una población ambulatoria de la Comunidad de Madrid.

INTRODUCTION: Cardiovascular diseases are responsible for the largest burden of global mortality. The study of the degree of knowledge of their population risk factors and cardiovascular risk is a priority preventive strategy. MATERIAL AND METHODS: A cross-sectional study with 369 people was performed. The sociodemographic variables were cardiovascular risk and perception as well as physical and anthropometric factors. The risk was stratified with the SCORE table. RESULTS: A total of 49.6% were men and 50.4% were women. The proportion of diagnosis was 23.8% in HTA, 39% in hypercholesterolemia, 31.4% in smoking, 26.3% in obesity and 4.6% in diabetes. Concordance between perceived and real cardiovascular risk was very weak. DISCUSSION: The population has good knowledge about diabetes and acceptable knowledge about hypertension, and hypercholesterolemia but knowledge in prediabetic states and perception of the associated cardiovascular risk is low.

Relación entre nivel de conocimiento sobre factores de riesgo cardiovascular y conducta de riesgo cardiovascular referida por las enfermeras / Relationship between level of knowledge about cardiovascular risk factors and cardiovascular risk behavior referred by nurses

Objetivos: determinar la relación entre el nivel de conocimiento sobre los factores de riesgo cardiovascular modificables y la conducta de riesgo cardiovascular referida por las enfermeras del Hospital Nacional Arzobispo Loayza. Material y métodos: el estudio fue descriptivo, correlacional. La muestra estuvo conformada por 107 enfermeras del Hospital Arzobispo Loayza. El muestreo fue probabilístico aleatorio simple, la recolección de datos se hizo a través de la técnica de encuesta, cuyo instrumento fue un cuestionario elaborado por las investigadoras y pasó por un proceso de validación con la correlación de Pearson, y la prueba alfa de Cronbach, para su confiabilidad. Resultados: El 56% del personal de enfermería posee un nivel de conocimiento medio acerca de los factores de riesgo cardiovascular modificable, y el 45% tiene una conducta de alto riesgo. Conclusiones: no existe relación entre el nivel de conocimientos acerca de los factores de riesgo cardiovascular y la conducta de riesgo cardiovascular en enfermeras.

Objectives: To determine the relationship between the level of knowledge about modifiable cardiovascular risk factors and cardiovascular risk behavior referred by nurses Arzobispo Loayza National Hospital. Material and Method: The study was descriptive correlational. The sample was 107 Arzobispo Loayza Hospital nurses, selected according to the inclusion criteria of a total of 423 nurses. The simple random sampling was probabilistic, data collection was done through the survey technique, the instrument was a questionnaire developed by the researchers themselves and went through a validation process with Pearson correlation and CronbachÆs alpha test for its reliability. Results: 56% of the nurses has a medium level of knowledge about modifiable cardiovascular risk factors and 45% had high-risk behavior. Conclusion: There is no relationship between the level of knowledge about cardiovascular risk factors and cardiovascular risk behavior in nurses.

Relación del soporte familiar y social en el cumplimiento del tratamiento de pacientes con tuberculosis pulmonar en centros de salud / Relationship of family and social support in implementing the treatment of patients with pulmonary tuberculosis in health

Objetivos: Determinar la relación del soporte familiar y social en el cumplimento del tratamiento de pacientes con Tuberculosis Pulmonar. Material y métodos: tipo de estudio descriptivo de corte transversal, correlacional. La población estuvo conformada por 52 pacientes que estuvieron registrados en la Estrategia Sanitaria Nacional de Prevención y Control de la Tuberculosis en los Centros de Salud: Flor de Amancaes y San Juan de Amancaes. Se utilizó como técnica la encuesta, a través de dos cuestionarios validados por juicio de expertos, instrumentos que midieron el soporte familiar y social en el cumplimiento del tratamiento. Resultados: Un 81,8% de los pacientes que recibieron nivel alto de soporte familiar y social presentaron cumplimiento del tratamiento, mientras que un 36.4%, que recibieron bajo nivel de soporte familiar y social presentaron ¿cumplimiento? del tratamiento. La diferencia encontrada resultó estadísticamente significativa (p=0,034). Mientras que un 59.6% de los pacientes cumplen con el tratamiento, y un 40,4% no lo cumplen. Conclusiones: el soporte familiar y social es un eje importante en la recuperación del paciente, ya que el paciente se siente más confiado y motivado a culminar con su tratamiento para recuperarse pronto y reinsertarse a su vida cotidiana.

Objectives: To determine the relationship of family and social support in the treatment compliance of patients with pulmonary tuberculosis. Material and methods: The study was a descriptive type of cross-sectional correlation of the 52 patients who were registered in the National Health Strategy for Prevention and Control of Tuberculosis in Health Centers: ¨Flor de Amancaes¨ and ¨San Juan de Amancaes.¨ Data collection: A survey was used as a technique and the survey was conducted through two questionnaires and validated by an expert judgment. The instruments that measure family and social support and adherence to treatment of patients with pulmonary tuberculosis have acceptable level´s of reliability. Results: 81.8% of the patients who received a high level of family and social support showed compliance, while 36.4% received a low level of family and social support showed compliance. The difference found was statistically significant (p =0.034). 59.6% of the patients complied with treatment, while 40.4% did not. Conclusions: family and social support is an important factor in the patient recovery axis, since the patient will feel more confident and motivated to finish the treatment and recover soon and reintegrate into their daily lives.

Perfil lipídico y consumo de frutas y verduras en un grupo de jóvenes de 10 a 19 años, según el índice de masa corporal / Lipid profile and consumption of fruits and vegetables in a youth group from 10-19 years according to body mass index

Introducción: El exceso de peso en niños y adolescentes es una pandemia que aumenta el riesgo de mortalidad por enfermedades crónicas no transmisibles. Se ha estimado que aun en etapas tempranas de la vida, el exceso de peso se asocia con alteraciones metabólicas; sin embargo, es necesario establecer si en nuestro medio estas alteraciones se evidencian en población menor de 19 años. Objetivo: Comparar el perfil lipídico y la ingesta de frutas y verduras, según el índice de masa corporal, en un grupo de jóvenes de 10 a 19 años, de la empresa promotora de salud SURA, sede de Medellín. Métodos: Estudio de corte transversal, en el que participaron 103 jóvenes obesos, 120 con sobrepeso y 214 con un índice de masa corporal normal. En condiciones basales y ayuno de 10 horas, se evaluó colesterol total, c-LDL, c-HDL y triglicéridos. La ingesta de verduras y frutas se determinó mediante recordatorio de 24 horas. Resultados: Los datos de c-LDL en el grupo de obesos, sobrepeso y control fueron, respectivamente: 95 ± 32, 96 ± 53 y 80 ± 24 mg/dL (p = 0,000); para los mismos grupos, los datos de triglicéridos fueron: 116 ± 65, 112 ± 69 y 88 ± 52 mg/dL (p = 0,000). El c-HDL en los 3 grupos fue: 52 ± 14, 53 ± 12 y 56±14 mg/dL (p = 0,013), respectivamente. Se evidenció una asociación significativa entre el mayor consumo de frutas y la menor concentración de triglicéridos entre los participantes con sobrepeso (p = 0,035). No fue habitual la ingesta de frutas y verduras. Conclusiones: El alto índice de masa corporal promueve un perfil lipídico aterogénico. Son necesarias acciones para promover hábitos alimentarios saludables.

Introduction: Childhood overweight is a pandemic that increases the risk of chronic non-communicable diseases. It has been estimated that being overweight is associated with metabolic disorders; even in early stages of life. However, it is necessary to establish whether this association is observed in Colombian population between 10-19 years old. Objective: To compare lipid profile and fruit and vegetable intakes, according to body mass index, in subjects aged 10-19 in a health insurance company (SURA) from Medellin. Methods: One hundred an three obese, 120 overweight, and 214 children with normal body mass index participated in a cross-sectional study. We compared total cholesterol, LDL-C, HDL-C and triglycerides between groups; at baseline and after 10-hour fasting period. Fruit and vegetable intakes were determined by 24-hour dietary record. Results: LDL-C levels in obese, overweight and control group were, respectively: 95 ± 32, 96 ± 53 and 80 ± 24 mg/dL (P = .000). Triglycerides levels in the same groups were: 116 ± 65, 112 ± 69 and 88 ± 52 mg/dL (P = .000). HDL-C levels in the 3 groups were: 52 ± 14, 53 ± 12 and 56 ± 14 mg/dL (P = .013). A significant inverse association between fruit intake and triglyceride levels in overweight participants was observed (P = .035). Fruit and vegetable intake were unusual. Conclusions: A high body mass index promotes an atherogenic lipid profile. It is necessary to implement actions to promote healthy habits associated with diet.

Socioeconomic status and health inequalities for cardiovascular prevention among elderly Spaniards.

INTRODUCTION AND OBJECTIVES: Although it is known that social factors may introduce inequalities in cardiovascular health, data on the role of socioeconomic differences in the prescription of preventive treatment are scarce. We aimed to assess the relationship between the socioeconomic status of an elderly population at high cardiovascular risk and inequalities in receiving primary cardiovascular treatment, within the context of a universal health care system. METHODS: Cross-sectional study of 7447 individuals with high cardiovascular risk (57.5% women, mean age 67 years) who participated in the PREDIMED study, a clinical trial of nutritional interventions for cardiovascular prevention. Educational attainment was used as the indicator of socioeconomic status to evaluate differences in pharmacological treatment received for hypertension, diabetes, and dyslipidemia. RESULTS: Participants with the lowest socioeconomic status were more frequently women, older, overweight, sedentary, and less adherent to the Mediterranean dietary pattern. They were, however, less likely to smoke and drink alcohol. This socioeconomic subgroup had a higher proportion of coexisting cardiovascular risk factors. Multivariate analysis of the whole population found no differences between participants with middle and low levels of education in the drug treatment prescribed for 3 major cardiovascular risk factors (odds ratio [95% confidence interval]): hypertension (0.75 [0.56-1.00] vs 0.85 [0.65-1.10]); diabetic participants (0.86 [0.61-1.22] vs 0.90 [0.67-1.22]); and dyslipidemia (0.93 [0.75-1.15] vs 0.99 [0.82-1.19], respectively). CONCLUSIONS: In our analysis, socioeconomic differences did not affect the treatment prescribed for primary cardiovascular prevention in elderly patients in Spain. Free, universal health care based on a primary care model can be effective in reducing health inequalities related to socioeconomic status.